Blame Game on Insulin Costs Leaves Patients Behind

During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.

Source: WebMD Health - April 11, 2019 Category: Consumer Health News Source Type: news